Passage Bio logo

Passage Bio share price today

(PASG)

Passage Bio share price is $0.76 & ₹65.22 as on 7 Jan 2025, 2.30 'hrs' IST

$0.76

-0.07

(-8.32%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Passage Bio share price in Dollar and Rupees. Guide to invest in Passage Bio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Passage Bio, along with analyst recommendations, forecasts, and comprehensive financials.

Passage Bio share price movements

  • Today's Low: $0.75
    Today's High: $0.83

    Day's Volatility :9.4%

  • 52 Weeks Low: $0.45
    52 Weeks High: $1.79

    52 Weeks Volatility :74.8%

Passage Bio Returns

PeriodPassage Bio IncSector (Health Care)Index (Russel 2000)
3 Months
35.41%
-8.4%
0.0%
6 Months
-3.04%
-3.8%
0.0%
1 Year
-21.79%
-0.1%
0.0%
3 Years
-84.73%
2.9%
-19.8%

Passage Bio Key Statistics

in dollars & INR

Previous Close
$0.829
Open
$0.819
Today's High
$0.83
Today's Low
$0.752
Market Capitalization
$35.0M
Today's Volume
$797.6K
52 Week High
$1.79
52 Week Low
$0.451
Revenue TTM
$0.0
EBITDA
$-84.7M
Earnings Per Share (EPS)
$-1.17
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-63.55%

How to invest in Passage Bio from India?

It is very easy for Indian residents to invest directly in Passage Bio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Passage Bio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Passage Bio or PASG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Passage Bio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Passage Bio shares which would translate to 1.129 fractional shares of Passage Bio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Passage Bio, in just a few clicks!

Returns in Passage Bio for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Passage Bio investment value today

Current value as on today

₹74,921

Returns

₹25,079

(-25.08%)

Returns from Passage Bio Stock

₹28,302 (-28.3%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Passage Bio

-32.14%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in Passage Bio from India has reduced in the last 30 days as on Jan 7, 2025. -32.14% less purchase transactions for Passage Bio in the last 30 days versus the previous period.

-26%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Passage Bio on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -26% less investors are searching Passage Bio in the last 30 days versus the previous period.

Global Institutional Holdings in Passage Bio

  • Orbimed Advisors, LLC

    15.90%

  • Vestal Point Capital LP

    9.88%

  • New Leaf Venture Partners, L.L.C.

    4.04%

  • Erste Asset Management GmbH

    3.98%

  • Vanguard Group Inc

    3.35%

  • TANG CAPITAL MANAGEMENT LLC

    2.43%

Analyst Recommendation on Passage Bio

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Passage Bio(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Passage Bio

What analysts predicted

Upside of 952.63%

Current:

$0.76

Target:

$8.00

Insights on Passage Bio

  • Price Movement

    In the last 7 days, PASG stock has moved up by 24.7%
  • PASG vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 34.3%
  • PASG vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 141.0%

Passage Bio Technicals Summary

Sell

Neutral

Buy

Passage Bio is currently in a neutral trading position according to technical analysis indicators.

Passage Bio Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Passage Bio Inc
3.62%
-3.04%
-21.79%
-84.73%
-96.27%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Passage Bio Inc
NA
NA
NA
-1.11
-0.64
-0.34
NA
2.03
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Passage Bio Inc
Buy
$35.0M
-96.27%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Passage Bio

passage bio, inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (cns) diseases. the company develops pbgm01, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional glb1 gene encoding lysosomal acid beta-galactosidase (ãŸ-gal) for infantile gm1; pbft02, which utilizes an aav1 capsid to deliver to the brain a functional granulin, or grn, gene encoding progranulin for the treatment of ftd caused by a deficiency of progranulin; and pbkr03, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional galc gene encoding the hydrolytic enzyme galactosylceramidase, for infantile krabbe disease. it has a strategic research collaboration with the trustees of the university of pennsylvania's gene therapy program; and collaboration agreement, and a development services and clinical supply agreement with catalent maryland, inc. the company was fou
Organization
Passage Bio
Employees
58
CEO
Dr. William Chou M.D.
Industry
Health Technology

Management People of Passage Bio

NameTitle
Dr. William Chou M.D.
President, CEO & Director
Mr. Edgar B. Cale Esq., J.D.
General Counsel & Company Secretary
Dr. James M. Wilson M.D., Ph.D.
Co-Founder & Chief Scientific Advisor
Ms. Kathleen Borthwick
Senior VP, CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Stuart M. Henderson
Senior Vice President of Corporate Development & Investor Relations
Eden Fucci
Senior Vice President of Technical Operations
Dr. Sue Browne Ph.D.
Senior Vice President of Research & Development
Dr. Karl Whitney Ph.D.
Senior Vice President of Global Regulatory Affairs

Important FAQs about investing in Passage Bio from India :

What is Passage Bio share price today?

Passage Bio share price today stands at $0.76, Open: $0.82 ; Previous Close: $0.83 ; High: $0.83 ; Low: $0.75 ; 52 Week High: $1.79 ; 52 Week Low: $0.45. The stock opens at $0.82, after a previous close of $0.83. The stock reached a daily high of $0.83 and a low of $0.75, with a 52-week high of $1.79 and a 52-week low of $0.45.

Can Indians buy Passage Bio shares?

Yes, Indians can invest in the Passage Bio (PASG) from India.

With INDmoney, you can buy Passage Bio at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Passage Bio at zero transaction cost.

How can I buy Passage Bio shares from India?

It is very easy to buy Passage Bio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Passage Bio be purchased?

Yes, you can buy fractional shares of Passage Bio with INDmoney app.

What are the documents required to start investing in Passage Bio stocks?

To start investing in Passage Bio, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Passage Bio

Today’s highest price of Passage Bio (PASG) is $0.83.

Today’s lowest price of Passage Bio (PASG) is $0.75.

What is today's market capitalisation of Passage Bio

Today's market capitalisation of Passage Bio PASG is 35.0M

What is the 52 Week High and Low Range of Passage Bio

  • 52 Week High

    $1.79

  • 52 Week Low

    $0.45

What are the historical returns of Passage Bio?

  • 1 Month Returns

    3.62%

  • 3 Months Returns

    -3.04%

  • 1 Year Returns

    -21.79%

  • 5 Years Returns

    -96.27%

Who is the Chief Executive Officer (CEO) of Passage Bio

Dr. William Chou M.D. is the current Chief Executive Officer (CEO) of Passage Bio.